129 related articles for article (PubMed ID: 34033093)
21. Cell cycle dependent effects of u.v.-radiation on p53 expression and retinoblastoma protein phosphorylation.
Haapajärvi T; Kivinen L; Pitkänen K; Laiho M
Oncogene; 1995 Jul; 11(1):151-9. PubMed ID: 7624123
[TBL] [Abstract][Full Text] [Related]
22. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
23. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S
Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424
[TBL] [Abstract][Full Text] [Related]
24. WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.
Cuddihy AR; Jalali F; Coackley C; Bristow RG
Mol Cancer Ther; 2008 Apr; 7(4):980-92. PubMed ID: 18413811
[TBL] [Abstract][Full Text] [Related]
25. Selenomethionine induces p53 mediated cell cycle arrest and apoptosis in human colon cancer cells.
Goel A; Fuerst F; Hotchkiss E; Boland CR
Cancer Biol Ther; 2006 May; 5(5):529-35. PubMed ID: 16627976
[TBL] [Abstract][Full Text] [Related]
26. Cell-cycle arrest and p53 accumulation induced by geldanamycin in human ovarian tumour cells.
McIlwrath AJ; Brunton VG; Brown R
Cancer Chemother Pharmacol; 1996; 37(5):423-8. PubMed ID: 8599864
[TBL] [Abstract][Full Text] [Related]
27. DNA damage-induced cell cycle checkpoints involve both p53-dependent and -independent pathways: role of telomere repeat binding factor 2.
Narayan S; Jaiswal AS; Multani AS; Pathak S
Br J Cancer; 2001 Sep; 85(6):898-901. PubMed ID: 11556843
[TBL] [Abstract][Full Text] [Related]
28. Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells.
Tu Y; Kim E; Gao Y; Rankin GO; Li B; Chen YC
Int J Oncol; 2016 Jun; 48(6):2657-65. PubMed ID: 27082635
[TBL] [Abstract][Full Text] [Related]
29. Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses.
Lee JH; Byun DS; Lee MG; Ryu BK; Kang MJ; Chae KS; Lee KY; Kim HJ; Park H; Chi SG
Int J Cancer; 2008 Apr; 122(7):1573-84. PubMed ID: 18059034
[TBL] [Abstract][Full Text] [Related]
30. [Relationships between p53 induction, cell cycle arrest and survival of normal human fibroblasts following DNA damage].
Ceraline J; Deplanque G; Duclos B; Limacher JM; Vincent F; Goldblum S; Bergerat JP
Bull Cancer; 1997 Nov; 84(11):1007-16. PubMed ID: 9536982
[TBL] [Abstract][Full Text] [Related]
31. Induction of p53-Independent Apoptosis and G1 Cell Cycle Arrest by Fucoidan in HCT116 Human Colorectal Carcinoma Cells.
Park HY; Park SH; Jeong JW; Yoon D; Han MH; Lee DS; Choi G; Yim MJ; Lee JM; Kim DH; Kim GY; Choi IW; Kim S; Kim HS; Cha HJ; Choi YH
Mar Drugs; 2017 May; 15(6):. PubMed ID: 28555064
[TBL] [Abstract][Full Text] [Related]
32. Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis.
Gomez-Manzano C; Fueyo J; Kyritsis AP; McDonnell TJ; Steck PA; Levin VA; Yung WK
J Natl Cancer Inst; 1997 Jul; 89(14):1036-44. PubMed ID: 9230885
[TBL] [Abstract][Full Text] [Related]
33. Ligustrazine induces the colorectal cancer cells apoptosis via p53-dependent mitochondrial pathway and cell cycle arrest at the G0/G1 phase.
Bian Y; Yang L; Sheng W; Li Z; Xu Y; Li W; Zeng L
Ann Palliat Med; 2021 Feb; 10(2):1578-1588. PubMed ID: 33302638
[TBL] [Abstract][Full Text] [Related]
34. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
[TBL] [Abstract][Full Text] [Related]
35. Assays to measure p53-dependent and -independent apoptosis.
Phillips DC; Garrison SP; Jeffers JR; Zambetti GP
Methods Mol Biol; 2009; 559():143-59. PubMed ID: 19609755
[TBL] [Abstract][Full Text] [Related]
36. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard.
Bhatia U; Danishefsky K; Traganos F; Darzynkiewicz Z
Clin Cancer Res; 1995 Aug; 1(8):873-80. PubMed ID: 9816057
[TBL] [Abstract][Full Text] [Related]
37. Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.
Duan L; Perez RE; Hansen M; Gitelis S; Maki CG
Cancer Biol Ther; 2014; 15(12):1600-12. PubMed ID: 25482935
[TBL] [Abstract][Full Text] [Related]
38. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
[TBL] [Abstract][Full Text] [Related]
39. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
40. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
